Active, Not Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)
NCT06112275
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +6 more
- Locations
-
- The Royal Children's Hospital Melbourne, Australia